BSX vs. SOLV: Boston Scientific vs. Solventum Stock Comparison
How do Boston Scientific (BSX) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Boston Scientific (BSX) and Solventum (SOLV) both belong to the Health Care Equipment & Supplies industry, though BSX is classified under Health Care Equipment while SOLV falls under Health Care Supplies.
Boston Scientific (BSX) carries decades of public-market history since May 19, 1992, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the BSX side.
| Profile Item | BSX | SOLV |
|---|---|---|
| Name | Boston Scientific Corp. | Solventum Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Supplies |
| Market Capitalization | 61.96 billion USD | 15.36 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | May 19, 1992 | March 26, 2024 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BSX | SOLV |
|---|---|---|
| Total Return (1Y) | -55.98% | 25.89% |
| Total Return (3Y, Annualized) | -5.05% | -- |
| Total Return (5Y, Annualized) | 0.57% | -- |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BSX | SOLV |
|---|---|---|
| Volatility (1Y, Annualized) | 40.16% | 30.06% |
| Beta (5Y) | 0.57 | 0.62 |
| Max Drawdown (5Y) | -61.55% | -39.98% |
| Avg. Volume (3M) | 19.73M | 1.05M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BSX | SOLV |
|---|---|---|
| Sharpe Ratio (1Y) | -1.50 | 0.72 |
| Sortino Ratio (1Y) | -1.80 | 1.08 |
Profitability
ROE (TTM)
Both Boston Scientific (BSX) at 14.12% and Solventum (SOLV) at 3.19% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
BSX
Health Care Equipment & Services industry group
14.12%
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
SOLV
Health Care Equipment & Services industry group
3.19%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- SOLV
- 3.19%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Boston Scientific (BSX) at 16.62% retains a top-quartile share of revenue as profit, ahead of Solventum (SOLV) at 1.91%, which keeps about the industry-typical share.
BSX
Health Care Equipment & Services industry group
16.62%
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
SOLV
Health Care Equipment & Services industry group
1.91%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- SOLV
- 1.91%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Boston Scientific (BSX) at 19.05% operates in the top operating margin quartile, ahead of Solventum (SOLV) at 6.82%, which runs around its industry’s norm.
BSX
Health Care Equipment & Services industry group
19.05%
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
SOLV
Health Care Equipment & Services industry group
6.82%
- Max
- 35.43%
- Q3
- 14.14%
- SOLV
- 6.82%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BSX | SOLV |
|---|---|---|
| ROE (TTM) | 14.12% | 3.19% |
| ROA (TTM) | 5.87% | 2.29% |
| Net Margin (TTM) | 16.62% | 1.91% |
| Operating Margin (TTM) | 19.05% | 6.82% |
| Gross Margin (TTM) | 67.98% | 55.13% |
Growth
Revenue Growth
Boston Scientific (BSX) at 19.87% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.
EPS Growth
Both companies show strong earnings momentum, but Solventum (SOLV) at 221.74% is the standout with EPS growth above its industry range; Boston Scientific (BSX) at 55.20% also sits in the top quartile.
Growth Metrics
| Metric | BSX | SOLV |
|---|---|---|
| Revenue Growth (YoY) | 19.87% | 0.86% |
| Revenue Growth (3Y CAGR) | 16.54% | 0.79% |
| EPS Growth (YoY) | 55.20% | 221.74% |
| EPS Growth (3Y CAGR) | 62.75% | 4.51% |
Financial Strength
Current Ratio (MRQ)
Both Boston Scientific (BSX) at 1.37 and Solventum (SOLV) at 1.03 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
BSX
Health Care Equipment & Services industry group
1.37
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
SOLV
Health Care Equipment & Services industry group
1.03
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- SOLV
- 1.03
- Min
- 0.30
Debt / Equity (MRQ)
Boston Scientific (BSX) at 0.46 carries an industry-typical debt-to-equity mix, while Solventum (SOLV) at 1.10 uses more debt funding than most peers.
BSX
Health Care Equipment & Services industry group
0.46
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
SOLV
Health Care Equipment & Services industry group
1.10
- Max
- 1.88
- SOLV
- 1.10
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | BSX | SOLV |
|---|---|---|
| Current Ratio (MRQ) | 1.37 | 1.03 |
| Debt / Equity (MRQ) | 0.46 | 1.10 |
| Net Debt / EBITDA | 2.04 | 4.66 |
Dividends
Dividend Yield (TTM)
Neither Boston Scientific (BSX) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Boston Scientific (BSX) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BSX | SOLV |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Boston Scientific (BSX) at 18.04 sits in the cheaper P/E ratio quartile, while Solventum (SOLV) at 101.55 trades above its peer range — a wide earnings-valuation gap relative to industry peers.
BSX
Health Care Equipment & Services industry group
18.04
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
SOLV
Health Care Equipment & Services industry group
101.55
- SOLV
- 101.55
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Boston Scientific (BSX) at 2.94 and Solventum (SOLV) at 1.88 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
BSX
Health Care Equipment & Services industry group
2.94
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
SOLV
Health Care Equipment & Services industry group
1.88
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- SOLV
- 1.88
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Boston Scientific (BSX) at 2.42 and Solventum (SOLV) at 3.20 are valued close to their industries’ norm against book — neither stands out from peers.
BSX
Health Care Equipment & Services industry group
2.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
SOLV
Health Care Equipment & Services industry group
3.20
- Max
- 11.68
- Q3
- 6.12
- SOLV
- 3.20
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | BSX | SOLV |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | 101.55 |
| P/S Ratio (TTM) | 2.94 | 1.88 |
| P/B Ratio (MRQ) | 2.42 | 3.20 |
| Free Cash Flow Yield (TTM) | 4.02% | 1.31% |